☆ 4.7 Meeting Abstract

Combination ipilimumab and nivolumab in recurrent/ metastatic nasopharyngeal carcinoma (R/M NPC): Updated efficacy and safety analysis of NCT03097939

ANNALS OF ONCOLOGY (2020)

Get Full Text
Add to Collection

Journal

ANNALS OF ONCOLOGY
Volume 31, Issue -, Pages S1347-S1347

Publisher

ELSEVIER
DOI: 10.1016/j.annonc.2020.10.260

Keywords

-

Categories

Oncology

Funding

  1. Bristol-Myers Squibb
  2. Ono pharmaceuticals

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.